References
- 1. National Center for Health Statistics. Leading causes of death, 1900–1998. 2000. http://www.cdc.gov/nchs/data/dvs/lead1900_98.pdf.
- 2. Forsberg JA, Wedin R, Boland PJ, Healey JH. Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease? Clin OrthopRelat Res. 2017 Apr; 475(4):1252-1261. doi: 10.1007/s11999-016-5187-3.10.1007/s11999-016-5187-3
- 3. Gobbini E, Ezzalfani M, Dieras V, Bachelot T, Brain E, Debled M, Jacot W, Mouret-Reynier MA, Goncalves A, Dalenc F, Patsouris A, Ferrero JM, Levy C, Lorgis V, Vanlemmens L, Lefeuvre-Plesse C, Mathoulin-Pelissier S, Petit T, Uwer L, Jouannaud C, Leheurteur M, Lacroix-Triki M, Cleaud AL, Robain M, Courtinard C, Cailliot C, Perol D, Delaloge S. Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort. Eur J Cancer. 2018 Jun; 96:17-24. doi: 10.1016/j.ejca.2018.03.015.10.1016/j.ejca.2018.03.015
- 4. Kyriakopoulos CE, Chen YH, Carducci MA, Liu G, Jarrard DF, Hahn NM, Shevrin DH, Dreicer R, Hussain M, Eisenberger M, Kohli M, Plimack ER, Vogelzang NJ, Picus J, Cooney MM, Garcia JA, DiPaola RS, Sweeney CJ. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial. J Clin Oncol. 2018 Apr 10; 36(11):1080-1087. doi: 10.1200/JCO.2017.75.3657.10.1200/JCO.2017.75.3657
- 5. Hage WD, Aboulafia AJ, Aboulafia DM. Incidence, location, and diagnostic evaluation of metastatic bone disease. Orthop Clin North Am. 2000 Oct; 31(4):515-28,vii. doi: 10.1016/s0030-5898(05)70171-1.10.1016/S0030-5898(05)70171-1
- 6. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006 Oct 15; 12(20 Pt 2):6243s-6249s. doi: 10.1158/1078-0432.CCR-06-0931.10.1158/1078-0432.CCR-06-093117062708
- 7. Rades D, Schild SE, Abrahm JL. Treatment of painful bone metastases. Nat. Rev. Clin. Oncol. 2010; 7,220-229.
- 8. Saravana-Bawan S, David E, Sahgal A, Chow E. Palliation of bone metastases-exploring options beyond radiotherapy. Ann Palliat Med. 2019 Apr; 8(2):168-177. doi: 10.21037/apm.2018.12.04.10.21037/apm.2018.12.0430691279
- 9. Tanaka A, Katagiri H, Murata H, Wasa J, Miyagi M, Honda Y, Takahashi M. Surgery for femoral metastases. Bone Joint J. 2020 Mar; 102-B(3):285-292. doi: 10.1302/0301-620X.102B3.BJJ-2019-0976.R1.10.1302/0301-620X.102B3.BJJ-2019-0976.R132114815
- 10. Howard EL, Shepherd KL, Cribb G, Cool P. The validity of the Mirels score for predicting impending pathological fractures of the lower limb. Bone Joint J. 2018 Aug; 100-B(8):1100-1105. doi: 10.1302/0301-620X.100B8.BJJ-2018-0300.R1.10.1302/0301-620X.100B8.BJJ-2018-0300.R130062934
- 11. Philipp TC, Mikula JD, Doung YC, Gundle KR. Is There an Association Between Prophylactic Femur Stabilization and Survival in Patients with Metastatic Bone Disease? Clin Orthop Relat Res. 2020 Mar; 478(3):540-546. doi: 10.1097/CORR.0000000000000803.10.1097/CORR.0000000000000803714509132168065
- 12. Bongers MER, Groot OQ, Thio Q, Bramer JAM, Verlaan JJ, Newman ET, Raskin KA, Lozano-Calderon SA, Schwab JH. Prospective study for establishing minimal clinically important differences in patients with surgery for lower extremity metastases. Acta Oncol. 2021; 60:714-720.10.1080/0284186X.2021.189033333630699
- 13. Miller BJ, Carmody Soni EE, Gibbs CP, Scarborough MT. Intramedullary nails for long bone metastases: Why do they fail? Orthopedics. 2011, Apr 11; 34(4). doi: 10.3928/01477447-20110228-12.10.3928/01477447-20110228-1221469628
- 14. Goodman MA, Weiss KR. Surgical approach to metastatic bone disease. Operat. Tech. Orthop. 24; 85-90.10.1053/j.oto.2014.02.009
- 15. Meynard P, Seguineau A, Laumonerie P, Fabre T, Foltran D, Niglis L, Descamps J, Bouthors C, Lebaron M, Szymanski C, Sailhan F, Bonnevialle P. members of the SoFCOT. Surgical management of proximal femoral metastasis: Fixation or hip replacement? A 309 case series. Orthop Traumatol Surg Res. 2020 Oct; 106(6):1013-1023. doi: 10.1016/j.otsr.2020.05.007.10.1016/j.otsr.2020.05.00732778439
- 16. Harvey N, Ahlmann ER, Allison DC, Wang L, Menendez LR. Endoprostheses last longer than intramedullary devices in proximal femur metastases. Clin Orthop Relat Res. 2012 Mar; 470(3):684-91. doi: 10.1007/s11999-011-2038-0.10.1007/s11999-011-2038-0327018221879409
- 17. Sørensen MS, Horstmann PF, Hindsø K, Petersen MM. Use of endoprostheses for proximal femur metastases results in a rapid rehabilitation and low risk of implant failure. A prospective population-based study. J Bone Oncol. 2019 Oct 22; 19:100264. doi: 10.1016/j.jbo.2019.100264.10.1016/j.jbo.2019.100264691185831871883
- 18. Willeumier JJ, van de Sande MAJ, van der Wal RJP, Dijkstra PDS. Trends in the surgical treatment of pathological fractures of the long bones: based on a questionnaire among members of the Dutch Orthopaedic Society and the European Musculo-Skeletal Oncology Society (EMSOS). Bone Joint J. 2018 Oct; 100-B(10):1392-1398. doi: 10.1302/0301-620X.100B10.BJJ-2018-0239.R1.10.1302/0301-620X.100B10.BJJ-2018-0239.R130295518
- 19. Yu Z, Xiong Y, Shi R, Min L, Zhang W, Liu H, Fang X, Tu C, Duan H. Surgical management of metastatic lesions of the proximal femur with pathological fractures using intramedullary nailing or endoprosthetic replacement. Mol Clin Oncol. 2018 Jan; 8(1):107-114. doi: 10.3892/mco.2017.1503.10.3892/mco.2017.1503577279329399352
- 20. Gusho CA, Clayton B, Mehta N, Colman MW, Gitelis S, Blank AT. Survival and outcomes of modular endoprosthetic reconstruction of the proximal femur for primary and non-primary bone tumors: Single institutional results. J Orthop. 2021 May 7; 25:145-150. doi: 10.1016/j.jor.2021.05.008.10.1016/j.jor.2021.05.008813463234025058
- 21. Janssen SJ, Kortlever JT, Ready JE, Raskin KA, Ferrone ML, Hornicek FJ, Lozano-Calderon SA, Schwab JH. Complications After Surgical Management of Proximal Femoral Metastasis: A Retrospective Study of 417 Patients. J Am Acad Orthop Surg. 2016 Jul; 24(7):483-94. doi: 10.5435/JAAOS-D-16-00043.10.5435/JAAOS-D-16-0004327227983
- 22. Angelini A, Trovarelli G, Berizzi A, Pala E, Breda A, Maraldi M, Ruggieri P. Treatment of pathologic fractures of the proximal femur. Injury. 2018 Nov; 49 Suppl 3:S77-S83. doi: 10.1016/j.injury.2018.09.044.10.1016/j.injury.2018.09.04430415673